Literature DB >> 2655881

Global epidemiology of meningococcal disease.

B Schwartz1, P S Moore, C V Broome.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2655881      PMCID： PMC358088          DOI： 10.1128/CMR.2.Suppl.S118

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN： 0893-8512            Impact factor:   26.132


× No keyword cloud information.
  41 in total

1.  The carrier state: Neisseria meningitidis.

Authors:  C V Broome
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

2.  Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine.

Authors:  A L Reingold; C V Broome; A W Hightower; G W Ajello; G A Bolan; C Adamsbaum; E E Jones; C Phillips; H Tiendrebeogo; A Yada
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

3.  Meningococcal disease and season in sub-Saharan Africa.

Authors:  B M Greenwood; A K Bradley; R A Wall
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

4.  Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program.

Authors:  G W Counts; D F Gregory; J G Spearman; B A Lee; G A Filice; K K Holmes; J M Griffiss
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

5.  Epidemic group C meningococcal meningitis in Upper Volta, 1979.

Authors:  C V Broome; M A Rugh; A A Yada; L Giat; H Giat; J M Zeltner; W R Sanborn; D W Fraser
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

6.  Factors preceding the onset of meningococcal disease, with special emphasis on passive smoking, symptoms of ill health.

Authors:  B Haneberg; T Tønjum; K Rodahl; T W Gedde-Dahl
Journal:  NIPH Ann       Date:  1983-12

7.  Longitudinal study of asymptomatic meningococcal carriage in two Belgian populations of schoolchildren.

Authors:  P De Wals; C Gilquin; S De Maeyer; A Bouckaert; A Noel; M F Lechat; A Lafontaine
Journal:  J Infect       Date:  1983-03       Impact factor: 6.072

8.  Possible association of mycoplasma and viral respiratory infections with bacterial meningitis.

Authors:  K Krasinski; J D Nelson; S Butler; J P Luby; H Kusmiesz
Journal:  Am J Epidemiol       Date:  1987-03       Impact factor: 4.897

9.  Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts.

Authors:  P De Wals; L Hertoghe; I Borlée-Grimée; S De Maeyer-Cleempoel; G Reginster-Haneuse; A Dachy; A Bouckaert; M F Lechat
Journal:  J Infect       Date:  1981-03       Impact factor: 6.072

10.  Meningococcal serotypes and serogroup B disease in north-west Europe.

Authors:  J T Poolman; I Lind; K Jónsdóttir; L O Frøholm; D M Jones; H C Zanen
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321
View more
  51 in total

1.  HmbR, a hemoglobin-binding outer membrane protein of Neisseria meningitidis, undergoes phase variation.

Authors:  A R Richardson; I Stojiljkovic
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996.

Authors:  H R Yusuf; R W Rochat; W S Baughman; P M Gargiullo; B A Perkins; M D Brantley; D S Stephens
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

3.  Structural bioinformatics of Neisseria meningitidis LD-carboxypeptidase: implications for substrate binding and specificity.

Authors:  Yasmeen Rashid; M Kamran Azim
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

4.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 5.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

Review 6.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 7.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

8.  Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.

Authors:  M G Danelli; N M Batoreu; M D Lacerda; C R Ferreira; J D Cardoso; J M Peralta; C E Frasch
Journal:  Curr Microbiol       Date:  1995-09       Impact factor: 2.188

9.  Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B.

Authors:  M Van Looveren; P Vandamme; M Hauchecorne; M Wijdooghe; F Carion; D A Caugant; H Goossens
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

10.  Risk and prevention of meningococcal disease among education workers: A review.

Authors:  Philippe De Wals; Pierre Deshaies; Gaston De Serres; Bernard Duval; Lise Goulet; Bernard Pouliot; Sylvie Ricard; Maurice Poulin
Journal:  Can J Infect Dis       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.